Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Mar 31, 2024 | (FY)Mar 31, 2023 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | (FY)Mar 31, 2020 | (FY)Mar 31, 2019 | (FY)Mar 31, 2018 | (FY)Mar 31, 2017 | (FY)Mar 31, 2016 | (FY)Mar 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | ||||||||||
Cash from operating activities | 480.63%11.32B | 145.37%1.95B | -171.58%-4.3B | 261.58%6B | -37.99%1.66B | -23.74%2.68B | 42.68%3.51B | -49.32%2.46B | 879.87%4.86B | -125.08%-622.65M |
Net profit before non-cash adjustment | 27.07%4.89B | 38.54%3.85B | 1,122.24%2.78B | -570.43%-271.8M | -97.83%57.78M | 11.63%2.66B | 31.80%2.38B | -34.74%1.81B | -26.44%2.77B | 120.10%3.77B |
Total adjustment of non-cash items | 24.75%2.17B | 4.52%1.74B | 38.77%1.66B | -65.54%1.2B | 70.42%3.48B | 0.14%2.04B | 26.71%2.04B | -4.65%1.61B | -2.02%1.69B | 4.49%1.72B |
-Depreciation and amortization | 5.01%1.99B | 10.12%1.89B | 1.76%1.72B | -16.30%1.69B | 5.95%2.02B | 7.85%1.91B | 12.40%1.77B | 2.07%1.57B | 3.86%1.54B | 18.01%1.48B |
-Reversal of impairment losses recognized in profit and loss | ---- | ---- | ---- | -28.89%642.46M | --903.47M | ---- | ---- | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -147.20%-119.55M | 107.29%253.3M |
-Share of associates | -105.47%-3.84M | 479.22%70.32M | 151.41%12.14M | -130.42%-23.61M | 388.59%77.61M | -61.25%15.88M | 88.84%40.99M | -77.88%21.71M | -3.28%98.14M | -74.63%101.47M |
-Disposal profit | 124.44%16.8M | 21.87%-68.75M | -73.75%-88M | -188.59%-50.65M | 20.70%-17.55M | 7.02%-22.13M | 58.96%-23.8M | ---57.99M | --0 | --0 |
-Net exchange gains and losses | -56.69%-630.82M | -41.28%-402.59M | -64.47%-284.96M | -144.70%-173.26M | 82.14%387.6M | 329.65%212.81M | -191.84%-92.67M | -66.35%100.9M | 161.29%299.86M | 125.53%114.76M |
-Pension and employee benefit expenses | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 60.34%11.01M | --6.87M |
-Other non-cash items | 225.01%797.7M | -19.31%245.44M | 134.31%304.17M | -921.54%-886.43M | 251.38%107.9M | -120.57%-71.28M | 1,332.16%346.59M | 80.29%-28.13M | 39.97%-142.69M | -174.61%-237.69M |
Changes in working capital | 217.07%4.26B | 58.37%-3.64B | -272.14%-8.74B | 370.67%5.08B | 7.33%-1.88B | -122.41%-2.02B | 4.80%-910M | -340.14%-955.88M | 106.51%398.06M | -596.92%-6.11B |
-Change in receivables | 67.91%-477.64M | 7.40%-1.49B | -192.32%-1.61B | 224.24%1.74B | 3,014.62%536.96M | 101.40%17.24M | -46.50%-1.23B | -613.12%-842.7M | 118.30%164.23M | 7.85%-897.52M |
-Change in inventory | 311.28%4.01B | 74.00%-1.9B | -3,060.16%-7.3B | 132.89%246.56M | -19.04%-749.72M | 60.51%-629.78M | -142.78%-1.59B | -171.48%-656.84M | 114.47%918.95M | -1,217.03%-6.35B |
-Change in payables | 154.09%212.43M | -7.50%-392.76M | -114.70%-365.34M | 272.22%2.49B | 8.39%-1.44B | -217.21%-1.58B | 217.57%1.34B | 161.77%423.21M | -160.31%-685.12M | 341.05%1.14B |
-Provision for loans, leases and other losses | 265.73%514.79M | -73.59%140.76M | -11.67%532.94M | 374.84%603.38M | -233.87%-219.54M | -71.49%164M | 398.81%575.21M | --115.32M | ---- | ---- |
-Changes in other current assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --5.13M | ---- | ---- |
Dividends paid (cash flow from operating activities) | ||||||||||
Dividends received (cash flow from operating activities) | ||||||||||
Interest paid (cash flow from operating activities) | -51.53%-389.18M | -93.27%-256.84M | 21.65%-132.89M | 33.66%-169.61M | -42.44%-255.65M | -1.06%-179.48M | -18.56%-177.6M | -26.90%-149.8M | -2.17%-118.04M | 17.14%-115.54M |
Interest received (cash flow from operating activities) | 37.01%40.09M | 32.29%29.26M | -11.93%22.12M | -3.18%25.12M | -23.91%25.94M | -34.82%34.09M | -8.14%52.3M | 37.54%56.93M | 80.71%41.4M | 5.89%22.91M |
Tax refund paid | -9.65%-1.47B | -72.53%-1.34B | -579.90%-775.4M | 82.73%-114.05M | 54.98%-660.37M | -273.59%-1.47B | -74.34%-392.64M | 83.42%-225.21M | 10.23%-1.36B | -146.76%-1.51B |
Other operating cash inflow (outflow) | -42.64%61.03M | 97.46%106.41M | -93.94%53.89M | 1,573.80%889.69M | 1,577.31%53.15M | -65.57%3.17M | -54.94%9.21M | 56.04%20.43M | -84.20%13.09M | 62.10%82.87M |
Operating cash flow | 1,850.14%9.56B | 109.56%490.41M | -177.31%-5.13B | 705.80%6.63B | -22.94%823.3M | -64.42%1.07B | 38.80%3B | -37.01%2.16B | 260.05%3.43B | -219.05%-2.15B |
Investing cash flow | ||||||||||
Net PPE purchase and sale | 23.96%-1.56B | -88.87%-2.06B | -224.99%-1.09B | 61.80%-335.1M | 42.32%-877.15M | -43.51%-1.52B | 16.03%-1.06B | 43.75%-1.26B | 16.63%-2.24B | -129.43%-2.69B |
Net intangibles purchase and sale | -33.14%-444.06M | 2.36%-333.53M | -1,725.48%-341.6M | 81.61%-18.71M | 62.31%-101.76M | 33.78%-269.96M | -53.56%-407.64M | -5.71%-265.45M | -71.03%-251.11M | -78.87%-146.82M |
Net business purchase and sale | ---- | ---- | -172.85%-243.4M | --334.09M | ---- | ---- | ---- | ---1.12B | ---- | ---- |
Net investment product transactions | -1.11%-825.47M | 37.56%-816.39M | -2,021.29%-1.31B | -112.70%-61.64M | 243.47%485.19M | -809.33%-338.19M | --47.68M | --0 | ---- | --170M |
Advance cash and loans provided to other parties | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---243.6M | ---- | ---- |
Net changes in other investments | 180.92%237.34M | -208.78%-293.31M | 177.13%269.65M | -22.51%97.3M | 239.39%125.57M | -22.02%-90.09M | 79.15%-73.83M | -22,369.87%-354.09M | 102.26%1.59M | -461.53%-70.36M |
Investing cash flow | 25.83%-2.6B | -29.06%-3.5B | -17,108.87%-2.71B | 104.33%15.94M | 83.41%-368.15M | -48.58%-2.22B | 54.03%-1.49B | -30.29%-3.25B | 8.95%-2.49B | -121.62%-2.74B |
Financing cash flow | ||||||||||
Net issuance payments of debt | -110.81%-452.91M | -24.57%4.19B | 177.36%5.55B | -915.53%-7.18B | -1.44%880.26M | 112.31%893.11M | -60.11%420.66M | -73.16%1.05B | 78.30%3.93B | 136.46%2.2B |
Net common stock issuance | 385.15%10.13M | 100.34%2.09M | ---621.99M | --0 | -314.13%-711.11M | ---171.71M | ---- | -677.58%-602.48M | -101.64%-77.48M | 17,151.98%4.72B |
Increase or decrease of lease financing | -77.06%-422.81M | -11.11%-238.79M | -58.94%-214.91M | 9.73%-135.22M | -93.36%-149.79M | 6.20%-77.47M | 26.99%-82.59M | 0.71%-113.12M | 13.19%-113.92M | -0.59%-131.23M |
Cash dividends paid | -32.99%-574.75M | 2.04%-432.18M | -26,396.04%-441.16M | 99.63%-1.67M | -0.27%-451.05M | -49.96%-449.83M | 2.05%-299.97M | 12.85%-306.24M | -131.20%-351.39M | -69.25%-151.99M |
Net other fund-raising expenses | ---- | 0.00%-1K | ---1K | ---- | 66.67%-1K | -200.00%-3K | 50.00%-1K | 33.33%-2K | -50.00%-3K | 33.33%-2K |
Financing cash flow | -140.92%-1.44B | -17.67%3.52B | 158.44%4.28B | -1,594.63%-7.32B | -322.41%-431.7M | 409.35%194.1M | 16.68%38.11M | -99.04%32.66M | -49.02%3.39B | 798.76%6.64B |
Net cash flow | ||||||||||
Beginning cash position | 9.34%8.2B | -29.78%7.5B | -2.78%10.68B | -3.20%10.99B | -1.17%11.35B | 14.74%11.49B | -8.94%10.01B | 57.28%10.99B | 43.52%6.99B | 45.30%4.87B |
Current changes in cash | 983.28%5.53B | 114.31%510.23M | -435.78%-3.57B | -2,937.84%-665.56M | 102.45%23.45M | -161.83%-956.54M | 246.94%1.55B | -124.33%-1.05B | 146.10%4.33B | 34.67%1.76B |
Effect of exchange rate changes | 156.79%488.91M | -50.40%190.39M | 6.55%383.85M | 193.20%360.27M | -245.91%-386.56M | -56.57%-111.75M | -201.36%-71.38M | 121.77%70.42M | -189.58%-323.41M | 69.83%361.05M |
Cash adjustments other than cash changes | ---- | ---- | --1K | ---- | -100.00%-1K | 93,407,900.00%934.08M | --1K | ---- | ---- | 0.00%1K |
End cash Position | 73.35%14.22B | 9.34%8.2B | -29.78%7.5B | -2.78%10.68B | -3.20%10.99B | -1.17%11.35B | 14.74%11.49B | -8.94%10.01B | 57.28%10.99B | 43.52%6.99B |
Free cash flow | 462.92%7.47B | 69.22%-2.06B | -208.18%-6.69B | 2,035.48%6.18B | 57.85%-319.36M | -153.02%-757.77M | 245.94%1.43B | -51.03%413.18M | 116.70%843.8M | -1,270.29%-5.05B |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |